Reviewed by Peptide Treatments Medical Advisory Board
Danuglipron: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for Danuglipron.
Back to Danuglipron overviewData source: Side effect data comes from clinical trials, preclinical research, and anecdotal reports. No FDA-approved labeling exists for this compound.
Reported Side Effects (8 items)
| # | Side Effect |
|---|---|
| 1 | Nausea (dose-dependent, most common) |
| 2 | Diarrhea |
| 3 | Vomiting |
| 4 | Constipation |
| 5 | Headache |
| 6 | GI adverse events consistent with GLP-1 receptor agonist class |
| 7 | Theoretical risk of gastroparesis (class effect) |
| 8 | Theoretical risk of pancreatitis (class effect, not confirmed in trials) |